SCHEMBL28008564

SCHEMBL28008564

COC[C@H]1CNCCN1.O=C(Cl)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
LTA4H P09960 1/20 0.48
HTR2C P28335 1/20 0.43
GLA P06280 1/20 0.41
TSHR P16473 2/20 0.39
CPB1 P15086 1/20 0.36
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28098362 0.84 ALDH1A1 (0.59) ALDH1A1LTA4HHTR2CGLATSHR
Piperazine SCHEMBL28816742 0.79 ALDH1A1 (0.79) ALDH1A1HTR2CGLATSHRMAPK1
SCHEMBL3393626 0.77 GLA (0.62) ALDH1A1LTA4HHTR2CGLATSHR
SCHEMBL28307564 0.76 ALDH1A1 (0.59) ALDH1A1HTR2CTSHR
Azetidine SCHEMBL28049251 0.76 ALDH1A1 (0.79) ALDH1A1HTR2CGLATSHRMAPK1
SCHEMBL17069 0.75 LTA4H (0.61) LTA4HTSHRPOLBSLC6A2SLC6A3
SCHEMBL17070 0.75 LTA4H (0.61) LTA4HTSHRPOLBSLC6A2SLC6A3
SCHEMBL6299585 0.75 LTA4H (0.61) LTA4HTSHRPOLBSLC6A2SLC6A3
SCHEMBL14348098 0.74 TSHR (0.43) ALDH1A1HTR2CTSHRCPB1CYP2C9
Hydrochloric Acid SCHEMBL16259 0.74 LTA4H (0.59) LTA4HTSHRPOLBSLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104662015-A Complement pathway modulators and uses thereof NOVARTIS AG 2015-05-27 CN disclosed